Study guide

12.1 Local Anaesthesia

MFDS Part 1 Membership of the Faculty of Dental Surgery

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

Current Exam Facts How to Use This Guide Eligibility, Booking & the MFDS Pathway

2 Basic Sciences, History Taking & Clinical Assessment

1.1 Head & Neck Anatomy and Underpinning Basic Sciences 1.2 History Taking, Communication & Clinical Examination 1.3 Special Tests, Investigations & Diagnostic Accuracy 1.4 Differential Diagnosis, Triage & When to Biopsy 1.5 Dental Anomalies & Developmental Conditions

3 Cariology, Operative Dentistry & Endodontics

2.1 Cariology & Caries Diagnosis 2.2 Caries Management & Prevention 2.3 Operative Dentistry & Cavity Preparation 2.4 Endodontics 2.5 Tooth Surface Loss & Tooth Discolouration

4 Periodontology & Prosthodontics

3.1 Periodontology 3.2 Fixed Prosthodontics 3.3 Removable Prosthodontics 3.4 Occlusion & Occlusal Assessment

5 Paediatric Dentistry, Orthodontics & Dental Trauma

4.1 Paediatric Dentistry 4.2 Orthodontics 4.3 Dental Trauma 4.4 Orthodontic Assessment, Indices & Referral 4.5 Impacted Teeth & Radiographic Localisation

6 Oral Surgery, Treatment Planning & Prevention

5.1 Oral Surgery & Extractions 5.2 Treatment Planning & Patient Management 5.3 Prevention & Health Promotion

7 Cardiovascular, Respiratory & Endocrine Disease

6.1 Cardiovascular Disease 6.2 Respiratory Disease 6.3 Endocrine Disease & Diabetes 6.4 Bleeding Disorders & Anticoagulation

8 Haematology, Infection & the Medically Compromised Patient

7.1 Haematology 7.2 Infectious Disease 7.3 The Medically Compromised Patient 7.4 Neurological & Gastrointestinal Disease

9 Medical Emergencies in Dental Practice

8.1 Medical Emergencies & Resuscitation 8.2 Anaphylaxis & Acute Allergy 8.3 Emergency Drugs & the Resuscitation Kit

10 Special Care Dentistry, Mental Health & Anxiety Management

9.1 Special Care Dentistry & Patients with Disability 9.2 Mental Health & Behavioural Science 9.3 Dental Anxiety & Behaviour Management

11 Oral Medicine — Mucosal Disease & Orofacial Pain

10.1 Oral Mucosal Disease & Lichen Planus 10.2 Vesiculobullous & Ulcerative Disorders 10.3 Candidiasis & Fungal Infections 10.4 Orofacial Pain & Neuropathic Disorders

12 Oral Pathology — Lesions, Cysts, Tumours & Salivary Glands

11.1 Premalignant Lesions & Oral Cancer 11.2 Odontogenic Cysts 11.3 Odontogenic & Non-Odontogenic Tumours 11.4 Salivary Gland Disease

13 Pharmacology — Local Anaesthesia, Analgesia & Sedation

12.1 Local Anaesthesia 12.2 Analgesics & NSAIDs 12.3 Conscious Sedation

14 Pharmacology — Antimicrobials, Prescribing & Drug Interactions

13.1 Antimicrobials & Antibiotic Stewardship 13.2 Prescribing & Drug Interactions

15 Dental Materials

14.1 Properties & Testing of Dental Materials 14.2 Amalgam & Metal Restorations 14.3 Composite Resin & Adhesive Dentistry 14.4 Impression Materials, Cements & Other Materials

16 Microbiology, Infection Control & Radiology

15.1 Oral Microbiology & Infection Control 15.2 Dental Radiology & Imaging 15.3 Radiation Protection

17 Law, Ethics, Professionalism & Evidence-Based Dentistry

16.1 Consent & Confidentiality 16.2 GDC Standards & Professionalism 16.3 Safeguarding & Duty of Candour 16.4 Evidence-Based Dentistry & Research Methods 16.5 Records, Information Governance & Regulation 16.6 Communication, Teamworking, Human Factors & Raising Concerns

18 Statistics, Dental Public Health, Critical Appraisal & Exam Strategy

17.1 Statistics & Critical Appraisal 17.2 Dental Public Health & Epidemiology 17.3 SBA Technique & Exam Strategy 17.4 Final Review & Key Points

12.1 Local Anaesthesia

Key Takeaways Explain This Topic AI

Local anaesthetics block voltage-gated sodium channels in nerve fibres, preventing depolarisation and action potential propagation; small myelinated Aδ pain fibres are blocked before larger Aα motor fibres

Lidocaine 2% with 1:80,000 epinephrine is the UK standard dental cartridge: 7 mg/kg with vasoconstrictor (500 mg adult absolute ceiling), delivering 44 mg lidocaine and approximately 27.5 micrograms epinephrine per 2.2 mL cartridge

Articaine 4% with 1:100,000 epinephrine is lipid-soluble and achieves effective buccal infiltration anaesthesia for mandibular molars; maximum 7 mg/kg (500 mg ceiling, 88 mg per cartridge)

True allergy to amide local anaesthetics (lidocaine, articaine, mepivacaine, bupivacaine) is rare; ester agents (benzocaine) carry a higher allergy risk via para-aminobenzoate (PABA) metabolites

Bupivacaine 0.5% with 1:200,000 epinephrine is long-acting (6–8 hours) at 2 mg/kg maximum (200 mg ceiling), suited to prolonged postoperative analgesia rather than routine restorative work

Last updated: August 2026

Mechanism of Action

Local anaesthetics block voltage-gated sodium channels on nerve axons. By binding to the open sodium channel from the intracellular side, they prevent sodium influx, abolish depolarisation, and halt action potential propagation. Recovery is spontaneous as the drug diffuses away.

Nerve Fibre Sensitivity

Different nerve fibres are blocked in a predictable order. Small, myelinated fibres are most sensitive because the local anaesthetic has a shorter distance to reach the nodes of Ranvier.

  • Fibre Type Function Myelin Sensitivity to LA
  • Aδ Sharp, fast pain Myelinated Blocked first
  • Aβ Touch, pressure Myelinated Blocked early
  • Aγ Muscle spindle tone Myelinated Blocked early
  • C Dull, slow pain Unmyelinated Blocked later
  • Aα Motor, proprioception Myelinated Blocked last

This explains the clinical sequence: patients report loss of sharp pain before loss of touch or motor function.

Agents Used in UK Dental Practice

All routinely used dental injectable anaesthetics in the UK are amides . Ester agents survive mainly as topical preparations.

  • Agent Concentration Vasoconstrictor Max Dose (with vasoconstrictor) Ceiling Duration Notes
  • Lidocaine 2% 1:80,000 epinephrine 7 mg/kg 500 mg 60–90 min UK standard; 44 mg per 2.2 mL cartridge

Articaine 4% 1:100,000 epinephrine 7 mg/kg 500 mg 60–120 min Lipid-soluble; effective buccal infiltration of mandibular molars; 88 mg per cartridge

Mepivacaine 3% Plain (no vasoconstrictor) 6.6 mg/kg 400 mg 30–45 min Short-acting; avoids epinephrine when contraindicated

Prilocaine 4% 1:200,000 epinephrine or felypressin 8 mg/kg 500 mg 30–60 min Methaemoglobinaemia risk at high dose; felypressin option for cardiac patients

Bupivacaine 0.5% 1:200,000 epinephrine 2 mg/kg 200 mg 6–8 h Long-acting; for prolonged postoperative analgesia; slow onset

Dose Calculation in Practice

A 70 kg adult receiving lidocaine 2% with 1:80,000 epinephrine :

  • Weight-based limit: 7 mg/kg × 70 kg = 490 mg (below the 500 mg absolute ceiling)
  • Cartridges to reach weight limit: 490 ÷ 44 mg ≈ 11 cartridges (lidocaine limit)

Epinephrine is the practical limiting factor : a healthy-adult epinephrine ceiling of approximately 200 micrograms per appointment ÷ 27.5 µg per cartridge ≈ 7–8 cartridges . For patients with cardiac disease, the cautious epinephrine ceiling is approximately 40 micrograms (~1–2 cartridges).

Always use the most conservative of the weight-based and epinephrine-based limits.

Vasoconstrictors

Epinephrine (adrenaline) is added to local anaesthetics to cause local vasoconstriction, which:

  • Reduces systemic absorption, lowering toxicity risk and extending duration
  • Decreases bleeding at the operative site
  • Increases the effective maximum safe dose

Concentrations are expressed as ratios: 1:80,000 (lidocaine) and 1:100,000 (articaine). Felypressin (octapressin), a synthetic vasopressin analogue, is paired with prilocaine as an alternative for patients in whom epinephrine must be minimised, although it has weaker vasoconstrictor action.

Epinephrine Cautions

Epinephrine is not absolutely contraindicated in most cardiac disease, but caution is required. Safe practice:

  • Aspirate before injecting to avoid intravascular delivery
  • Use the lowest effective concentration and volume
  • Avoid in uncontrolled hyperthyroidism and unstable cardiac disease

Limit to approximately 40 micrograms epinephrine (about 1–2 cartridges of 1:80,000) for patients with significant cardiovascular disease

True absolute contraindications to epinephrine are rare; the risk of epinephrine is generally lower than the risk of giving plain anaesthetic that fails to achieve adequate analgesia

Allergy to Local Anaesthetics

True allergy is uncommon but clinically important.

Amide agents (lidocaine, articaine, mepivacaine, bupivacaine, prilocaine): allergy is rare. Reactions reported are more often vasovagal, toxicity, or epinephrine side effects.

Ester agents (benzocaine, procaine, amethocaine): higher allergy risk because they are metabolised to para-aminobenzoate (PABA) , a known allergen. Cross-reactivity exists across ester agents but not with amides.

If a patient reports a genuine amide allergy, refer to allergy testing — do not assume all amides are contraindicated without confirmation.

Topical Anaesthesia

Topical agents anaesthetise mucosa before injection or for minor procedures:

Lidocaine 5% ointment or 4% gel — widely used; amide, low allergy risk

Benzocaine 20% gel — ester; risk of methaemoglobinaemia , especially in children, infants, and patients with G6PD deficiency

Topical should be applied to dried mucosa for 1–2 minutes and used sparingly.

Injection Techniques

  • Technique Target Typical Use
  • Local infiltration Apex of maxillary teeth, mandibular incisors Restorative work where bone is thin
  • Inferior alveolar (ID) block Mandibular nerve at lingula Mandibular molars and premolars; thick cortical bone
  • Mental / incisive block Mental foramen Mandibular premolars and incisors
  • Posterior superior alveolar (PSA) block Maxillary molars Upper molars where infiltration is inadequate
  • Anterior superior alveolar (ASA) block Maxillary anteriors Upper anterior teeth

Intraligamentary (PDL) injection Periodontal ligament Single tooth, low systemic dose; delivers ~0.2 mL per root

Articaine's lipid solubility has expanded the role of buccal infiltration in the mandible, reducing reliance on the ID block for some restorative procedures, though the ID block remains standard for profound pulpal anaesthesia of mandibular molars.